SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Zelda Fitzgerald Synthetic CCD

PatientZelda Fitzgerald
Date of birth1996-07-24
IdentifiersMRN HR-ET004-SYN; SSN (made up) 000-04-8712
Document date2026-11-01
AuthorMargot Ellery, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Visit

Establishing primary care twelve days after discharge from a first psychiatric admission: provisional diagnosis and differential, antipsychotic monitoring baseline, missed periods, eating and exercise, and safety planning. Concerns: She wants to understand what happened and to make sure it never happens again; She wants to dance again and is afraid that medicines will make her gain weight; She is worried that her periods have stopped. [S]

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Risperidone 2 mg oral tablet, one tablet by mouth at bedtime (started in hospital)One tablet by mouth at bedtimeOral route2026-04-20 to 2026-06-08completedS
Lithium carbonate 300 mg oral capsule, one capsule by mouth twice dailyOne capsule by mouth twice dailyOral route2026-05-18activeS
Risperidone 1 mg oral tablet, one tablet by mouth at bedtime for one week, then stopOne tablet by mouth at bedtime for one weekOral route2026-06-08 to 2026-06-15completedS
Aripiprazole 10 mg oral tablet, one tablet by mouth once dailyOne tablet by mouth once dailyOral route2026-06-08activeS
Folic acid 0.4 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2026-09-14activeS

Procedures

ProcedureDatesStatusEvidence
Insertion of a levonorgestrel intrauterine system after a negative pregnancy test2026-09-14 to 2026-09-14completedS
Advance care planning conversation with a psychiatric advance directive, about 18 minutes2026-09-14 to 2026-09-14completedS

Immunizations

DateVaccineStatusEvidence
2026-09-14Influenza vaccine, 2026-2027 seasoncompletedS

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
about 1927Intensive ballet training from her late twenties, morning and afternoon, almost eight hours a dayD (CLM-0003)
1930First breakdown, with hospitalization for nervous exhaustion on a trip to EuropeD (CLM-0004)

Family History

No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.

Health Concerns

ConcernStatusEvidence
She wants to understand what happened and to make sure it never happens againactiveS
She wants to dance again and is afraid that medicines will make her gain weightactiveS
She is worried that her periods have stoppedactiveS

Assessment

Most recent measures: Leukocytes [#/volume] in Blood by Automated count 6.1 on 2026-05-11; Hemoglobin [Mass/volume] in Blood 12.6 on 2026-05-11; Platelets [#/volume] in Blood by Automated count 248 on 2026-05-11; Sodium [Moles/volume] in Serum or Plasma 139 on 2026-10-26; Potassium [Moles/volume] in Serum or Plasma 4 on 2026-10-26; Creatinine [Mass/volume] in Serum or Plasma 0.79 on 2026-10-26; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 103 on 2026-10-26; Glucose [Mass/volume] in Serum or Plasma 80 on 2026-06-01; Calcium [Mass/volume] in Serum or Plasma 9.6 on 2026-08-10; Thyrotropin [Units/volume] in Serum or Plasma 3.1 on 2026-10-26; Prolactin [Mass/volume] in Serum or Plasma 14 on 2026-08-10; Hemoglobin A1c/Hemoglobin.total in Blood 5.1 on 2026-08-10; Cholesterol [Mass/volume] in Serum or Plasma 174 on 2026-08-10; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 94 on 2026-08-10; Cholesterol in HDL [Mass/volume] in Serum or Plasma 62 on 2026-08-10; Triglyceride [Mass/volume] in Serum or Plasma 82 on 2026-08-10; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 3 on 2026-09-14; Total score [AUDIT-C] 1 on 2026-09-14; Lithium [Moles/volume] in Serum or Plasma 0.72 on 2026-10-26; Fasting glucose [Mass/volume] in Serum or Plasma 86 on 2026-08-10 [S]

Strengths and supports: Supports: her friend and roommate, her dance class, and the coordinated specialty care team; writing and painting are her strongest sources of purpose. She decides who is told about her health [S]

Problems

ProblemClinical statusVerificationCodeProvenance
First episode of psychosis with marked mood symptoms: about three weeks of little sleep, rapid speech, racing thoughts, grandiose plans and very long training days, then a voice commenting on her dancing and a belief that she was being watched and tested; tearful low mood since discharge. Diagnosis provisional; differential: bipolar I disorder with psychotic features, schizoaffective disorder (bipolar type), and schizophreniform disorder or schizophrenia, depending on whether the psychosis ever occurred apart from the mood symptoms. Synthetic modern episode linked to her documented first hospitalizationresolvedprovisional F29S — Synthetic modern coding of the documented first breakdown. Unspecified psychosis is coded until the course shows how the psychosis relates to the mood symptoms; superseded at the three-month visit.
Bipolar I disorder, most recent episode manic with psychotic features, in full remission: the working diagnosis at three months, when her history, her journal, and her roommate's account (given with her consent) showed that the voice and the belief she was watched began only after weeks of manic symptoms and ended with them, with no psychosis since. Remains provisional: it would be revised to schizoaffective disorder if psychosis ever lasted two weeks or more without a mood episode. Synthetic modern episode linked to the documented breakdown and its retrospective interpretationsactiveprovisional F31.74S — Synthetic modern diagnosis made from the course; the historical diagnoses stay in the claims.
Secondary amenorrhea: no periods for about four months before admission, during very heavy dance training at a low weight (BMI 18.7), with prolactin raised on risperidone; pregnancy test negativeresolvedconfirmed N91.1S — Synthetic presenting finding linked to her documented training; resolved when her periods returned.
Acute viral gastroenteritis (vomiting and watery diarrhea for two days, roommate with the same illness), with mild dehydration; resolvedresolvedconfirmed A08.4S — Synthetic acute infection; not a historical claim.
Lithium level above the therapeutic range (1.4 mmol/L) during dehydration, with nausea and a worse fine tremor, without confusion or unsteadiness; lithium held and restarted; resolvedresolvedconfirmed T43.595AS — Synthetic medication adverse effect at a prescribed dose; ICD-10-CM classifies lithium salts with the other antipsychotics and neuroleptics.

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-05-11Leukocytes [#/volume] in Blood by Automated count6.110*3/uL4-11 10*3/uLNormalS
2026-05-11Hemoglobin [Mass/volume] in Blood12.6g/dL11.6-15 g/dLNormalS
2026-05-11Platelets [#/volume] in Blood by Automated count24810*3/uL150-400 10*3/uLNormalS
2026-05-11Sodium [Moles/volume] in Serum or Plasma139mmol/L135-145 mmol/LNormalS
2026-05-11Potassium [Moles/volume] in Serum or Plasma4mmol/L3.5-5.1 mmol/LNormalS
2026-05-11Creatinine [Mass/volume] in Serum or Plasma0.72mg/dL0.59-1.04 mg/dLNormalS
2026-05-11Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M116mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-05-11Glucose [Mass/volume] in Serum or Plasma84mg/dL70-99 mg/dLNormalS
2026-05-11Calcium [Mass/volume] in Serum or Plasma9.4mg/dL8.6-10.2 mg/dLNormalS
2026-05-11Thyrotropin [Units/volume] in Serum or Plasma2.1m[IU]/L0.45-4.5 mIU/LNormalS
2026-05-11Prolactin [Mass/volume] in Serum or Plasma62ng/mL4.8-23.3 ng/mLHighS
2026-05-11Hemoglobin A1c/Hemoglobin.total in Blood5%Below 5.7% is normal; 5.7 to 6.4% prediabetesNormalS
2026-05-11Cholesterol [Mass/volume] in Serum or Plasma168mg/dL<=199 mg/dLNormalS
2026-05-11Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation90mg/dL<=129 mg/dLNormalS
2026-05-11Cholesterol in HDL [Mass/volume] in Serum or Plasma64mg/dL>=50 mg/dLNormalS
2026-05-11Triglyceride [Mass/volume] in Serum or Plasma70mg/dL<=149 mg/dLNormalS
2026-05-11Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]11{score}S
2026-05-11Total score [AUDIT-C]2{score}S
2026-05-18Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]9{score}S
2026-06-01Sodium [Moles/volume] in Serum or Plasma134mmol/L135-145 mmol/LLowS
2026-06-01Potassium [Moles/volume] in Serum or Plasma3.4mmol/L3.5-5.1 mmol/LLowS
2026-06-01Creatinine [Mass/volume] in Serum or Plasma1.08mg/dL0.59-1.04 mg/dLHighS
2026-06-01Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M71mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-06-01Glucose [Mass/volume] in Serum or Plasma80mg/dL70-99 mg/dLNormalS
2026-06-01Lithium [Moles/volume] in Serum or Plasma1.4mmol/LMaintenance target 0.6 to 0.8 mmol/L; above 1.2 mmol/L is above the therapeutic rangeHighS
2026-06-08Sodium [Moles/volume] in Serum or Plasma139mmol/L135-145 mmol/LNormalS
2026-06-08Potassium [Moles/volume] in Serum or Plasma4.1mmol/L3.5-5.1 mmol/LNormalS
2026-06-08Creatinine [Mass/volume] in Serum or Plasma0.78mg/dL0.59-1.04 mg/dLNormalS
2026-06-08Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M105mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-06-08Lithium [Moles/volume] in Serum or Plasma0.8mmol/LMaintenance target 0.6 to 0.8 mmol/L; above 1.2 mmol/L is above the therapeutic rangeNormalS
2026-06-08Prolactin [Mass/volume] in Serum or Plasma66ng/mL4.8-23.3 ng/mLHighS
2026-06-08Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]7{score}S
2026-08-10Sodium [Moles/volume] in Serum or Plasma140mmol/L135-145 mmol/LNormalS
2026-08-10Potassium [Moles/volume] in Serum or Plasma4.2mmol/L3.5-5.1 mmol/LNormalS
2026-08-10Creatinine [Mass/volume] in Serum or Plasma0.8mg/dL0.59-1.04 mg/dLNormalS
2026-08-10Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M102mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-08-10Lithium [Moles/volume] in Serum or Plasma0.74mmol/LMaintenance target 0.6 to 0.8 mmol/L; above 1.2 mmol/L is above the therapeutic rangeNormalS
2026-08-10Thyrotropin [Units/volume] in Serum or Plasma2.9m[IU]/L0.45-4.5 mIU/LNormalS
2026-08-10Calcium [Mass/volume] in Serum or Plasma9.6mg/dL8.6-10.2 mg/dLNormalS
2026-08-10Prolactin [Mass/volume] in Serum or Plasma14ng/mL4.8-23.3 ng/mLNormalS
2026-08-10Fasting glucose [Mass/volume] in Serum or Plasma86mg/dL70-99 mg/dLNormalS
2026-08-10Hemoglobin A1c/Hemoglobin.total in Blood5.1%Below 5.7% is normal; 5.7 to 6.4% prediabetesNormalS
2026-08-10Cholesterol [Mass/volume] in Serum or Plasma174mg/dL<=199 mg/dLNormalS
2026-08-10Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation94mg/dL<=129 mg/dLNormalS
2026-08-10Cholesterol in HDL [Mass/volume] in Serum or Plasma62mg/dL>=50 mg/dLNormalS
2026-08-10Triglyceride [Mass/volume] in Serum or Plasma82mg/dL<=149 mg/dLNormalS
2026-08-10Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]4{score}S
2026-10-26Sodium [Moles/volume] in Serum or Plasma139mmol/L135-145 mmol/LNormalS
2026-10-26Potassium [Moles/volume] in Serum or Plasma4mmol/L3.5-5.1 mmol/LNormalS
2026-10-26Creatinine [Mass/volume] in Serum or Plasma0.79mg/dL0.59-1.04 mg/dLNormalS
2026-10-26Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M103mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-10-26Lithium [Moles/volume] in Serum or Plasma0.72mmol/LMaintenance target 0.6 to 0.8 mmol/L; above 1.2 mmol/L is above the therapeutic rangeNormalS
2026-10-26Thyrotropin [Units/volume] in Serum or Plasma3.1m[IU]/L0.45-4.5 mIU/LNormalS
2026-10-26Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]3{score}S
2026-09-14Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]3{score}S
2026-09-14Total score [AUDIT-C]1{score}S

Social History

Vital Signs

DateMeasureValueUnitProvenance
2026-05-11Body height165cmS
2026-05-11Body weight50.8kgS
2026-05-11Body mass index (BMI) [Ratio]18.7kg/m2S
2026-05-11Systolic blood pressure108mm[Hg]S
2026-05-11Diastolic blood pressure68mm[Hg]S
2026-05-11Heart rate78/minS
2026-05-11Respiratory rate14/minS
2026-05-11Body temperature36.6CelS
2026-05-11Oxygen saturation in Arterial blood by Pulse oximetry99%S
2026-05-18Body height165cmS
2026-05-18Body weight51kgS
2026-05-18Body mass index (BMI) [Ratio]18.7kg/m2S
2026-05-18Systolic blood pressure106mm[Hg]S
2026-05-18Diastolic blood pressure66mm[Hg]S
2026-05-18Heart rate76/minS
2026-05-18Respiratory rate14/minS
2026-05-18Body temperature36.5CelS
2026-05-18Oxygen saturation in Arterial blood by Pulse oximetry99%S
2026-06-08Body height165cmS
2026-06-08Body weight50.2kgS
2026-06-08Body mass index (BMI) [Ratio]18.4kg/m2S
2026-06-08Systolic blood pressure104mm[Hg]S
2026-06-08Diastolic blood pressure66mm[Hg]S
2026-06-08Heart rate74/minS
2026-06-08Respiratory rate14/minS
2026-06-08Body temperature36.6CelS
2026-06-08Oxygen saturation in Arterial blood by Pulse oximetry99%S
2026-08-10Body height165cmS
2026-08-10Body weight51.6kgS
2026-08-10Body mass index (BMI) [Ratio]19kg/m2S
2026-08-10Systolic blood pressure108mm[Hg]S
2026-08-10Diastolic blood pressure68mm[Hg]S
2026-08-10Heart rate70/minS
2026-08-10Respiratory rate14/minS
2026-08-10Body temperature36.6CelS
2026-08-10Oxygen saturation in Arterial blood by Pulse oximetry99%S
2026-10-26Body height165cmS
2026-10-26Body weight52.4kgS
2026-10-26Body mass index (BMI) [Ratio]19.2kg/m2S
2026-10-26Systolic blood pressure110mm[Hg]S
2026-10-26Diastolic blood pressure70mm[Hg]S
2026-10-26Heart rate68/minS
2026-10-26Respiratory rate14/minS
2026-10-26Body temperature36.5CelS
2026-10-26Oxygen saturation in Arterial blood by Pulse oximetry99%S
2026-06-01Body height165cmS
2026-06-01Body weight49.6kgS
2026-06-01Body mass index (BMI) [Ratio]18.2kg/m2S
2026-06-01Systolic blood pressure102mm[Hg]S
2026-06-01Diastolic blood pressure64mm[Hg]S
2026-06-01Heart rate104/minS
2026-06-01Respiratory rate16/minS
2026-06-01Body temperature37.7CelS
2026-06-01Oxygen saturation in Arterial blood by Pulse oximetry99%S
2026-09-14Body height165cmS
2026-09-14Body weight51.9kgS
2026-09-14Body mass index (BMI) [Ratio]19.1kg/m2S
2026-09-14Systolic blood pressure108mm[Hg]S
2026-09-14Diastolic blood pressure68mm[Hg]S
2026-09-14Heart rate68/minS
2026-09-14Respiratory rate14/minS
2026-09-14Body temperature36.6CelS
2026-09-14Oxygen saturation in Arterial blood by Pulse oximetry99%S

Encounters

DatePurposeStatusProvenance
2026-05-11Establishing primary care twelve days after discharge from a first psychiatric admission: provisional diagnosis and differential, antipsychotic monitoring baseline, missed periods, eating and exercise, and safety planningfinishedS
2026-05-18One-week review and psychiatry consultation with the coordinated specialty care teamfinishedS
2026-06-08Lithium level after the sick visit, prolactin, and the antipsychotic planfinishedS
2026-08-10Three-month review: lithium, thyroid, kidney and metabolic checks, and the diagnosis reviewedfinishedS
2026-10-26Six-month review: maintenance treatment, lithium monitoring, and movement checkfinishedS
2026-06-01Same-day sick visit for gastroenteritis on lithiumfinishedS
2026-09-14Periodic adult preventive visit with contraceptionfinishedS

Plan of Treatment

InterventionStatusGuidelineProvenance
Continue the antipsychotic started in hospital, with monitoring to the APA and ADA/APA standard: weight at every visit, blood pressure, fasting glucose or A1c and lipids at baseline, 12 weeks and yearly, prolactin because her periods have stopped, side-effect checks, and the AIMS at baseline and every six monthscompletedGL-APA-SCZ-2020, GL-ADA-APA-2004, GL-CMID-2026S
Psychiatry consultation with the first-episode psychosis coordinated specialty care team on the provisional diagnosis and how to settle it, a mood stabilizer to prevent another episode, and the antipsychotic choice given her raised prolactin and missed periodscompletedGL-CANMAT-BD-2018, GL-APA-SCZ-2020, GL-NIMH-CSCS
Reproductive health on psychiatric medicines: a pregnancy test before any new medicine, valproate avoided because of its risks in pregnancy, counseling on the risks of any mood stabilizer in pregnancy, contraception that suits her, folic acid, and planning with psychiatry before any pregnancycompletedGL-CANMAT-BD-2018, GL-CDC-SPR-2024S
Eating and exercise: the SCOFF screen, menstrual and energy review at each visit, a sports dietitian, and a graded return to dance with food matched to the training load; training hours watched as an early warning signcompletedGL-APA-SCZ-2020, GL-CANMAT-BD-2018S
Coordinated specialty care: a care coordinator, individual therapy with psychoeducation about mood and psychosis, education for the people she chooses, support to return to dance and writing, and a peer specialistcompletedGL-NIMH-CSC, GL-APA-SCZ-2020S
Sleep and early warning signs: regular sleep and wake times, no all-night writing or training, and a plan to call the team after two short nights or if training hours climbcompletedGL-CANMAT-BD-2018S
Lithium carbonate 300 mg twice daily after a negative pregnancy test, with 12-hour trough levels 5 to 7 days after starting and after any change, then every 3 to 6 months (target 0.6 to 0.8 mmol/L); creatinine and eGFR every 2 to 3 months for 6 months, then every 6 to 12; TSH once or twice in the first 6 months, then every 6 to 12; calcium yearly; and sick-day rules: hold it during vomiting, diarrhea or dehydration, and avoid anti-inflammatory painkillerscompletedGL-CANMAT-BD-2018, GL-CANMAT-BD-2023, GL-CMID-2026S
Switch from risperidone to aripiprazole: aripiprazole 10 mg daily with risperidone 1 mg for one week, then risperidone stopped; prolactin and periods checked at three monthscompletedGL-APA-SCZ-2020, GL-CANMAT-BD-2018S
Structured safety assessment, a written safety plan with early warning signs, lethal-means counseling, the 988 Suicide & Crisis Lifeline, the PHQ-9 at each visit, and safety review at every visitcompletedGL-SUICIDE-2024, GL-CMID-2026, GL-USPSTF-DEP-2023S
Lithium sick-day plan, written down and shared with her roommate with her consent: stop lithium during vomiting, diarrhea, fever with poor drinking, or heavy sweating without fluids, and call the clinic; restart when eating and drinking normally; no anti-inflammatory painkillers; and go to the emergency department for confusion, unsteadiness, slurred speech, or a coarse tremorcompletedGL-CANMAT-BD-2018, GL-CMID-2026S

Goals

GoalTargetStatusOutcomeProvenance
No manic, depressive or psychotic episode and no readmission through six months2026-10-26completedNo episode and no admission; lithium and aripiprazole continuedS
Lithium trough level 0.6 to 0.8 mmol/L with normal kidney and thyroid tests at six months2026-10-26completedLithium 0.72 mmol/L; creatinine 0.79 mg/dL; TSH 3.1 mIU/LS
Periods return and prolactin is normal by three months2026-08-10completedPeriods returned five weeks after the switch to aripiprazole; prolactin 14 ng/mLS
BMI at least 19, with food matched to her training, by six months2026-10-26completedBMI 19.2 at 52.4 kg, dancing about four hours a dayS
PHQ-9 score below 5 by six months2026-10-26completedPHQ-9 3S

Functional Status

Mental Status

Structured synthetic safety assessment on 2026-05-11: current ideation absent, intent absent, plan absent. Outpatient care with close follow-up. She has no thoughts of suicide or self-harm now and had none during the admission. Her risk is higher in the months after a first episode, and especially in a depressive phase after mania, so a written safety plan was made with her, with her own early warning signs (sleeping less, training for hours, racing thoughts, or feeling hopeless) and what to do about each. Lethal-means counseling: she has no firearm and no access to one; any medicine that is dangerous in overdose will be dispensed in small amounts while her mood is low. The 988 Suicide & Crisis Lifeline was given and saved in her phone, with the clinic number. Safety reviewed at every visit [S]